US OptionsDetailed Quotes
RIGL241220P7000
- 0.05
- 0.000.00%
15min DelayClose Dec 12 16:00 ET
0.00High0.00Low
0.05Open0.05Pre Close0 Volume4 Open Interest7.00Strike Price0.00Turnover340.81%IV63.44%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier8DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.0126Delta0.0034Gamma380.20Leverage Ratio-0.0178Theta-0.0001Rho-4.80Eff Leverage0.0009Vega
Rigel Pharmaceuticals Stock Discussion
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
Let's Get 30.+
No comment yet